ALYCE HANNAN: Open Payments
NPI 1073153235 · METROPOLIS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 39 payments from 15 companies in 2025. Trend: 2023 $1,628 · 2024 $1,656 · 2025 $749
Food & beverage: $749
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $228 |
| Novo Nordisk Inc | 4 | $77 |
| PFIZER INC. | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| Amgen Inc. | 3 | $49 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Exact Sciences Corporation | 2 | $34 |
| Lilly USA, LLC | 2 | $30 |
Products named: FARXIGA, BREZTRI, ELIQUIS, Kerendia, LEQVIO, TRELEGY ELLIPTA, Rybelsus, VOQUEZNA.
Industry payments across IL — which companies pay providers there.
